PLoS ONE,
Journal Year:
2015,
Volume and Issue:
10(5), P. e0124219 - e0124219
Published: May 27, 2015
Many
diseases
cause
significant
changes
to
the
concentrations
of
small
molecules
(aka
metabolites)
that
appear
in
a
person's
biofluids,
which
means
such
can
often
be
readily
detected
from
"metabolic
profile".
This
information
extracted
biofluid's
NMR
spectrum.
Today,
this
is
done
manually
by
trained
human
experts,
process
relatively
slow,
expensive
and
error-prone.
paper
presents
tool,
Bayesil,
quickly,
accurately
autonomously
produce
complex
(e.g.,
serum
or
CSF)
metabolic
profile
1D1H
requires
first
performing
several
spectral
processing
steps
then
matching
resulting
spectrum
against
reference
compound
library,
contains
"signatures"
each
relevant
metabolite.
these
are
novel
algorithms
our
step
views
as
an
inference
problem
within
probabilistic
graphical
model
rapidly
approximates
most
probable
profile.
Our
extensive
studies
on
diverse
set
mixtures,
show
Bayesil
find
concentration
all
NMR-detectable
metabolites
(~90%
correct
identification
~10%
quantification
error),
<5minutes
single
CPU.
These
results
demonstrate
fully-automatic
publicly-accessible
system
provides
quantitative
profiling
effectively
--
with
accuracy
meets
exceeds
performance
experts.
We
anticipate
tool
will
usher
high-throughput
metabolomics
enable
wealth
new
applications
clinical
settings.
Available
at
http://www.bayesil.ca.
Computational and Structural Biotechnology Journal,
Journal Year:
2016,
Volume and Issue:
14, P. 135 - 153
Published: Jan. 1, 2016
Metabonomics/metabolomics
is
an
important
science
for
the
understanding
of
biological
systems
and
prediction
their
behaviour,
through
profiling
metabolites.
Two
technologies
are
routinely
used
in
order
to
analyse
metabolite
profiles
fluids:
nuclear
magnetic
resonance
(NMR)
spectroscopy
mass
spectrometry
(MS),
latter
typically
with
hyphenation
a
chromatography
system
such
as
liquid
(LC),
configuration
known
LC-MS.
With
both
NMR
MS-based
detection
technologies,
identification
metabolites
sample
remains
significant
obstacle
bottleneck.
This
article
provides
guidance
on
methods
fluids
using
spectroscopy,
illustrated
examples
from
recent
studies
mice.
Chemical Reviews,
Journal Year:
2022,
Volume and Issue:
122(3), P. 3459 - 3636
Published: Jan. 7, 2022
Synthetic
molecular
probes,
chemosensors,
and
nanosensors
used
in
combination
with
innovative
assay
protocols
hold
great
potential
for
the
development
of
robust,
low-cost,
fast-responding
sensors
that
are
applicable
biofluids
(urine,
blood,
saliva).
Particularly,
metabolites,
neurotransmitters,
drugs,
inorganic
ions
is
highly
desirable
due
to
a
lack
suitable
biosensors.
In
addition,
monitoring
analysis
metabolic
signaling
networks
cells
organisms
by
optical
probes
chemosensors
becoming
increasingly
important
biology
medicine.
Thus,
new
perspectives
personalized
diagnostics,
theranostics,
biochemical/medical
research
will
be
unlocked
when
standing
limitations
artificial
binders
receptors
overcome.
this
review,
we
survey
synthetic
sensing
systems
have
promising
(future)
application
detection
small
molecules,
cations,
anions
aqueous
media
biofluids.
Special
attention
was
given
provide
readily
measurable
signal
through
dynamic
covalent
chemistry,
supramolecular
host-guest
interactions,
or
nanoparticles
featuring
plasmonic
effects.
This
review
shall
also
enable
reader
evaluate
current
performance
terms
sensitivity
selectivity
respect
practical
requirement,
thereby
inspiring
ideas
further
advanced
systems.
Critical Reviews in Food Science and Nutrition,
Journal Year:
2020,
Volume and Issue:
61(9), P. 1448 - 1469
Published: May 22, 2020
As
one
of
the
omics
fields,
metabolomics
has
unique
advantages
in
facilitating
understanding
physiological
and
pathological
activities
biology,
physiology,
pathology,
food
science.
In
this
review,
based
on
developments
analytical
chemistry
tools,
cheminformatics,
bioinformatics
methods,
we
highlight
current
applications
safety,
authenticity
quality,
traceability.
Additionally,
combined
use
with
other
techniques
for
"foodomics"
is
comprehensively
described.
Finally,
latest
advances,
practical
challenges
limitations,
requirements
related
to
application
are
critically
discussed,
providing
new
insight
into
analysis.
PLoS ONE,
Journal Year:
2015,
Volume and Issue:
10(5), P. e0124219 - e0124219
Published: May 27, 2015
Many
diseases
cause
significant
changes
to
the
concentrations
of
small
molecules
(aka
metabolites)
that
appear
in
a
person's
biofluids,
which
means
such
can
often
be
readily
detected
from
"metabolic
profile".
This
information
extracted
biofluid's
NMR
spectrum.
Today,
this
is
done
manually
by
trained
human
experts,
process
relatively
slow,
expensive
and
error-prone.
paper
presents
tool,
Bayesil,
quickly,
accurately
autonomously
produce
complex
(e.g.,
serum
or
CSF)
metabolic
profile
1D1H
requires
first
performing
several
spectral
processing
steps
then
matching
resulting
spectrum
against
reference
compound
library,
contains
"signatures"
each
relevant
metabolite.
these
are
novel
algorithms
our
step
views
as
an
inference
problem
within
probabilistic
graphical
model
rapidly
approximates
most
probable
profile.
Our
extensive
studies
on
diverse
set
mixtures,
show
Bayesil
find
concentration
all
NMR-detectable
metabolites
(~90%
correct
identification
~10%
quantification
error),
<5minutes
single
CPU.
These
results
demonstrate
fully-automatic
publicly-accessible
system
provides
quantitative
profiling
effectively
--
with
accuracy
meets
exceeds
performance
experts.
We
anticipate
tool
will
usher
high-throughput
metabolomics
enable
wealth
new
applications
clinical
settings.
Available
at
http://www.bayesil.ca.